0 التعليقات
0 المشاركات
275 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Regulatory Harmonization: Standard protocols and the Impact of Fast-Track Approval for Insulin Biosimilars Specific Technologies in the GCC Market regionThe strategic push towards localizing Biomanufacturing Industry segments is defining a significant portion of the GCC Biologics Market segment. This initiative is a response to national economic diversification strategies, such as Vision 2030 in Saudi Arabia, aimed at reducing reliance on global imports and establishing regional self-sufficiency in critical medicine supply....0 التعليقات 0 المشاركات 131 مشاهدة 0 معاينة
-
Antibodies Market Size Projected to Reach USD 792.37 Billion by 2032The global Antibodies Market, primarily driven by the therapeutic segment of monoclonal antibodies (mAbs), encompasses highly specific, engineered proteins used to target and neutralize specific cells or proteins in the body. These advanced biopharmaceuticals have revolutionized the treatment of complex diseases by offering high specificity, minimal off-target toxicity, and mechanisms of action...0 التعليقات 0 المشاركات 9 مشاهدة 0 معاينة
-
Global Osteoporosis Treatment Market Set to Reach USD 21.30 Billion by 2032, Driven by Aging Population and Breakthrough Therapies...Osteoporosis Treatment Market Growth Outlook The global Osteoporosis Treatment Market, valued at USD 13.85 billion in 2023, is projected to reach USD 21.30 billion by 2032, expanding at a CAGR of 4.9% (2024–2032). Growth is fueled by the rising geriatric population, increasing awareness of bone health, and the introduction of biosimilars and innovative therapies. Quick Insights Market...0 التعليقات 0 المشاركات 446 مشاهدة 0 معاينة
-
The Patent Cliff Wave: Tracking Major Biologic Expirations and the Influx of Biosimilar Competition Reshaping the Pharmaceutical Industry.The single most powerful economic catalyst for the biosimilars market is the ongoing wave of patent expirations, often referred to as the "patent cliff," affecting original biologic drugs. Biologics, which represent a significant portion of pharmaceutical spending, are protected by intellectual property rights that provide years of market exclusivity. Once these foundational patents expire, the...0 التعليقات 0 المشاركات 382 مشاهدة 0 معاينة